Nations Financial Group Inc. IA ADV Grows Holdings in Humana Inc. (NYSE:HUM)

Nations Financial Group Inc. IA ADV grew its holdings in Humana Inc. (NYSE:HUM) by 5.9% during the third quarter, HoldingsChannel.com reports. The firm owned 1,169 shares of the insurance provider’s stock after acquiring an additional 65 shares during the quarter. Nations Financial Group Inc. IA ADV’s holdings in Humana were worth $370,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in HUM. Pzena Investment Management LLC increased its stake in shares of Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after buying an additional 1,955,375 shares during the period. Ontario Teachers Pension Plan Board increased its stake in shares of Humana by 11,647.2% during the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after buying an additional 1,050,459 shares during the period. Marshall Wace LLP increased its stake in shares of Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after buying an additional 774,085 shares during the period. International Assets Investment Management LLC increased its stake in shares of Humana by 261,025.1% during the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after buying an additional 738,701 shares during the period. Finally, Steadfast Capital Management LP purchased a new position in shares of Humana during the first quarter valued at $158,813,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 2.2 %

Shares of HUM stock opened at $282.97 on Friday. The stock has a market cap of $34.07 billion, a P/E ratio of 25.06, a P/E/G ratio of 2.21 and a beta of 0.52. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18. The stock has a 50 day moving average of $284.64 and a 200 day moving average of $332.14. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, sell-side analysts expect that Humana Inc. will post 15.83 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.25%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Analyst Ratings Changes

Several brokerages have recently commented on HUM. Barclays raised their price target on Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. Oppenheimer cut their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research note on Thursday, October 3rd. Wells Fargo & Company cut their target price on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. UBS Group cut their target price on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Finally, Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and cut their target price for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.